NO852427L - Fremgangsmaate ved fremstilling av medisinske, kosmetiske preparater - Google Patents
Fremgangsmaate ved fremstilling av medisinske, kosmetiske preparaterInfo
- Publication number
- NO852427L NO852427L NO852427A NO852427A NO852427L NO 852427 L NO852427 L NO 852427L NO 852427 A NO852427 A NO 852427A NO 852427 A NO852427 A NO 852427A NO 852427 L NO852427 L NO 852427L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- substances
- reacted
- protein
- blood
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000002537 cosmetic Substances 0.000 title claims description 4
- 239000011573 trace mineral Substances 0.000 claims description 19
- 235000013619 trace mineral Nutrition 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 210000002381 plasma Anatomy 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241000894007 species Species 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 239000008239 natural water Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 239000006071 cream Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 102000004506 Blood Proteins Human genes 0.000 description 4
- 108010017384 Blood Proteins Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- -1 auxiliaries Substances 0.000 description 3
- 229910000365 copper sulfate Inorganic materials 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010010957 Copper deficiency Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 102000007397 Species specific proteins Human genes 0.000 description 1
- 108020005719 Species specific proteins Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU833582A HUT37342A (en) | 1983-10-17 | 1983-10-17 | Process for production of preparatives for medical cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO852427L true NO852427L (no) | 1985-06-14 |
Family
ID=10964641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852427A NO852427L (no) | 1983-10-17 | 1985-06-14 | Fremgangsmaate ved fremstilling av medisinske, kosmetiske preparater |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS61500358A (fi) |
| KR (1) | KR850700008A (fi) |
| AU (1) | AU3551084A (fi) |
| DE (1) | DE3490488T1 (fi) |
| DK (1) | DK273585A (fi) |
| FI (1) | FI852341A0 (fi) |
| GB (1) | GB2164848A (fi) |
| HU (1) | HUT37342A (fi) |
| NL (1) | NL8420264A (fi) |
| NO (1) | NO852427L (fi) |
| SE (1) | SE8502997D0 (fi) |
| WO (1) | WO1985001653A1 (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1243957A (en) * | 1983-06-03 | 1988-11-01 | Laszlo Bogdany | Compositions for cosmetic, health- and body- preserving use |
| FR2572287A1 (fr) * | 1984-10-26 | 1986-05-02 | Caola Kozmetikai | Procede de preparation de compositions cosmetiques medicinales |
| AU617661B2 (en) * | 1987-02-24 | 1991-12-05 | Thermalife International Pharmaceuticals Limited | A method for manufacturing cosmetical, health and body care products |
| US5527779A (en) * | 1988-03-23 | 1996-06-18 | Top Gold Pty Limited | Topically applied gold organic complex |
| NZ228367A (en) * | 1988-03-23 | 1992-02-25 | Smithkline Beecham Corp | Topical composition containing a gold compound for treating inflammatory conditions |
| US5013726A (en) * | 1989-09-12 | 1991-05-07 | Ivy Jeffery W | External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion |
| US5124320A (en) * | 1989-09-12 | 1992-06-23 | Ivy Jeffery W | An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion |
| US20070048387A1 (en) * | 2005-09-01 | 2007-03-01 | Edwards Jeffrey D | Tissue disruption treatment and composition for use thereof |
| CN103033632B (zh) * | 2012-12-12 | 2014-10-22 | 英科新创(厦门)科技有限公司 | Abo血型反定型胶体金试剂盒及制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU101771A1 (ru) * | 1954-05-04 | 1900-01-01 | А.А. Дыскин | Способ насыщени углекислым газом цитратной донорской крови и устройство дл осуществлени способа |
| SU523695A1 (ru) * | 1973-12-14 | 1976-08-05 | Курганский Научно-Исследовательский Институт Экспериментальной И Клинической Ортопедии И Травматологии | Способ остановки кровотечени |
| SU777903A1 (ru) * | 1978-12-26 | 1981-12-15 | Ленинградский Ордена Трудового Красного Знамени Научно-Исследовательский Институт Гематологии И Переливания Крови | Способ получени аминокислотного препарата дл парентерального питани |
| SU741877A1 (ru) * | 1979-06-06 | 1980-06-25 | За витель Р. Н. Ходанова | Способ лечени аллергических заболеваний |
-
1983
- 1983-10-17 HU HU833582A patent/HUT37342A/hu unknown
-
1984
- 1984-10-17 AU AU35510/84A patent/AU3551084A/en not_active Abandoned
- 1984-10-17 DE DE19843490488 patent/DE3490488T1/de not_active Withdrawn
- 1984-10-17 WO PCT/HU1984/000050 patent/WO1985001653A1/en active Application Filing
- 1984-10-17 JP JP59504031A patent/JPS61500358A/ja active Pending
- 1984-10-17 GB GB08514467A patent/GB2164848A/en not_active Withdrawn
- 1984-10-17 KR KR1019850700088A patent/KR850700008A/ko not_active Application Discontinuation
- 1984-10-17 NL NL8420264A patent/NL8420264A/nl unknown
-
1985
- 1985-06-12 FI FI852341A patent/FI852341A0/fi not_active Application Discontinuation
- 1985-06-14 NO NO852427A patent/NO852427L/no unknown
- 1985-06-17 SE SE8502997A patent/SE8502997D0/xx not_active Application Discontinuation
- 1985-06-17 DK DK273585A patent/DK273585A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK273585D0 (da) | 1985-06-17 |
| SE8502997L (sv) | 1985-06-17 |
| GB8514467D0 (en) | 1985-07-10 |
| DE3490488T1 (de) | 1985-10-17 |
| WO1985001653A1 (en) | 1985-04-25 |
| JPS61500358A (ja) | 1986-03-06 |
| FI852341L (fi) | 1985-06-12 |
| GB2164848A (en) | 1986-04-03 |
| KR850700008A (ko) | 1985-10-21 |
| FI852341A0 (fi) | 1985-06-12 |
| DK273585A (da) | 1985-06-17 |
| NL8420264A (nl) | 1985-09-02 |
| AU3551084A (en) | 1985-05-07 |
| HUT37342A (en) | 1985-12-28 |
| SE8502997D0 (sv) | 1985-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1277599C (en) | Vanadium - peroxide compositions as insulin mimickers | |
| CA2298645C (en) | Use of physiologically acceptable vanadium compounds, salts and complexes | |
| NO852427L (no) | Fremgangsmaate ved fremstilling av medisinske, kosmetiske preparater | |
| Sander et al. | Evidence for function of a metal ion in the activity of dihydroorotase from Zymobacterium oroticum | |
| KR100828494B1 (ko) | 피부주름개선용 화장품 에센스 조성물 및 그의 조성방법 | |
| US4863897A (en) | Protein and mineral water-containing cosmetic compositions | |
| US4839347A (en) | Composition for treating dehydration | |
| JP2004510402A (ja) | 難溶性ｉｉａ族錯体の酸性溶液 | |
| FR2546754A1 (fr) | Agents cosmetiques pour l'entretien de la sante et du corps | |
| Carruthers et al. | Biochemistry and physiology of epidermis | |
| RU2399367C1 (ru) | Способ оптимизации уровня тромбинового времени у новорожденных поросят с анемией | |
| Hirsch | Tissue Autoxidation Inhibitors: I. The Inhibition of DOPA Autoxidation by Extracts from Normal and Neoplastic Tissues | |
| FR2572287A1 (fr) | Procede de preparation de compositions cosmetiques medicinales | |
| Nomura et al. | CIII The Capillary in the Human Vestibular Labyrinth: A Histochemical Staining Technique | |
| US3017325A (en) | Therapeutic composition for topical application and method of applying the same | |
| Sheker et al. | Silver allantoinate for the topical treatment of burns | |
| BE900935A (fr) | Procede de preparation de compositions cosmetiques medicinales. | |
| Carroll | Phenolsulfotransferase in the developing rat | |
| RU2392927C1 (ru) | СПОСОБ НОРМАЛИЗАЦИИ УРОВНЯ α2 АНТИПЛАЗМИНА ПРИ АНЕМИИ У НОВОРОЖДЕННЫХ ТЕЛЯТ И ПОРОСЯТ | |
| RU2406483C2 (ru) | СПОСОБ СНИЖЕНИЯ УРОВНЯ α2 АНТИПЛАЗМИНА У НОВОРОЖДЕННЫХ ПОРОСЯТ С АНЕМИЕЙ | |
| RU2818836C1 (ru) | Способ коррекции железодефицитной анемии у телят-молочников | |
| RU2383334C1 (ru) | Способ нормализации содержания в крови фибрина у новорожденных поросят с анемией | |
| CN103232538B (zh) | 一种巯基化改性的胶原钙复合物 | |
| SU829115A1 (ru) | Способ лечени и профилактики желу-дОчНО-КишЕчНыХ зАбОлЕВАНий СЕльСКО-ХОз йСТВЕННыХ жиВОТНыХ | |
| RU2349308C1 (ru) | СПОСОБ НОРМАЛИЗАЦИИ УРОВНЯ α2 АНТИПЛАЗМИНА У НОВОРОЖДЕННЫХ ПОРОСЯТ С АНЕМИЕЙ |